Currently, the treatment for insulin-dependent diabetes mellitus patients mainly involves obtaining a normal blood glucose value (below 8.0 mmol/L prior to large meals for adult diabetes patients) by delivery of exogenous insulin via conventional injection pen or insulin pump multiple times per day (Rodger, 1991). This evidence concerns the gene INS and diabetes mellitus.